Clinical trial
Acute Neurological ICU Sedation Trial (ANIST)
Dexmedetomidine (Precedex, Hospira) is a "super" selective alpha2-agonist - 8-10x more avid binding to alpha2 receptors than clonidine - and may have particularly favorable characteristics as a continuous i.v. infusion sedative for critically ill neuroscience patients. Its combination of anxiolysis, analgesia, without undue lethargy may make it an ideal agent where frequent neurological examinations are important (12). Unclear, however, is whether Precedex is superior to current common i.v. sedation protocols, and if there are any undue concerns of this agent on cerebral physiology and cortical stimulation.
Category | Value |
---|---|
Date last updated at source | 2013-04-11 |
Study type(s) | Interventional |
Expected enrolment | 60 |
Study start date | 2005-04-01 |
Estimated primary completion date | 2008-06-01 |